focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Series D Loan Restructure and Equity Issue

15 Mar 2021 07:00

RNS Number : 2266S
Oilex Ltd
15 March 2021
 

ASX-RNS Announcement

 

 

15 March 2021

 

ASX: OEX

AIM: OEX

Series D Loan Restructure and Equity Issue

 

The Board of Oilex Limited (the Company) is pleased to announce that it has entered into an amendment agreement to vary the repayment obligations for its Series D loan funding facility (GBP£225,000). Furthermore, the Company has secured additional equity investment of GBP £0.35 million to increase its working capital flexibility and reduce its financial debt obligations.

 

Amendment to Series D Loan Funding Agreement (GBP £225,000)

 

Pursuant to the amendment agreement with Lombard Bank Plc, the loan repayment date has been extended from 31 March 2021 to 30 June 2021. All other terms remain the same with no fees applicable to the amendment. The loan is currently drawn down to GBP £185,000.

 

Equity Capital Raising

 

The Company has arranged an equity capital raising, with existing sophisticated shareholders, to secure further funding of £0.35 million (A$0.63 million) through the subscription of 250,000,000 new shares at GBP 0.14pence (0.252 AUD cents) per share (Subscription).

 

Funds raised from the Subscription are intended to be applied towards increasing the Company's working capital base and debt reduction. The additional funding will support the Company's initiative to implement the settlement with GSPC, which, as most recently announced on 15 February 2021, the Company and GSPC are in advanced discussions on. Completion of the Subscription is anticipated on or about 19 March 2021 and is conditional, inter alia, upon admission of the shares the subject of the Subscription to trading on AIM.

 

The shares, the subject of the Subscription, will rank pari passu in all respects with the existing shares. Application will be made in due course to the London Stock Exchange for the shares (Subscription Shares) to be admitted to trading on AIM with a further announcement at that time. The issue of the Subscription Shares is under Listing Rule 7.1A with the applicable Appendix 3B to be submitted shortly.

 

Shares in Lieu of Fees

 

The Company advises that it has issued 4,642,858 new ordinary shares as consideration in lieu of fees payable to consultants. These new ordinary shares were issued at a price of GBP0.14 pence (0.252 AUD cents) per share. (Consultants Shares). These shares are issued under the Company's Listing Rule 7.1 capacity with the applicable Appendix 3B to be submitted shortly.

 

 

Managing Director of Oilex, Joe Salomon, said;

 

"The Company continues to advance discussions with GSPC to acquire GSPC's 55% participating interest in the Cambay PSC, albeit with some delays due to Covid-19 related impediments. Additionally, Oilex has continued to advance negotiations with third parties to provide finance, including working capital, to Oilex for this acquisition. The Company is working to reach complete these negotiations as soon as possible.

 

We remain confident of a successful outcome and we thank our shareholders for their ongoing support and patience."

 

The Company advises that the discussions with GSPC and potential financiers have not reached completion and there can be no certainty that any agreement will be reached. Further announcements will be made as new information comes to hand. 

 

Listing Rule 3.10.5A Disclosure

 

The Company provides the following information as required under ASX Listing Rule 3.10.5A in respect of the shares issued under the Company's 10% Placement Capacity under Listing Rule 7.1A.

 

a) The dilutive effect of the Placement under LR 7.1A on existing shareholders is as follows:

 

Number of shares on issue prior to the issue of the Placement Shares under LR7.1A:

 

- Excluding the 4,642,858 shares issued under LR7.1

4,166,776,024

- Including the 4,642,858 shares issued under LR7.1

4,171,418,882

 

 

Number of shares issued pursuant to LR7.1A

250,000,000

 

 

Dilutive effect of the share issue under LR 7.1A

 

- Excluding the 4,642,858 shares issued under LR7.1

5.66%

- Including the 4,642,858 shares issued under LR7.1

5.65%

 

b) The shares issued under Listing Rule 7.1A were issued to exempt, sophisticated and professional investors as it was considered to be the most efficient mechanism for raising funds at this time.

 

c) There were no underwriting arrangements entered into pursuant to the capital raising.

 

d) Fees applicable to the placement including consulting fees were GBP £21,000.

 

Section 708A(5)(e) Statement

 

Pursuant to the issue of the Consultants Shares and Subscription shares, Oilex gives notice under section 708A(5)(e) of the Corporations Act (Cth) (Act) that:

 

1) Oilex issued the shares without disclosure to investors under Part 6D.2 of the Act;

 

2) As at the date of this notice, Oilex has complied with:

a) the provisions of Chapter 2M of the Act as they apply to Oilex; and

b) section 674 of the Act; and

 

3) As at the date of this notice, there is no information that is 'excluded information' within the meaning of sections 708A(7) and 708(8) of the Act.

 

 

AIM Admission and Total Voting Rights

 

Following admission of the Subscription shares, the Company's share capital and total voting rights will comprise 4,421,418,882 shares. The Company does not hold any shares in treasury. Consequently, 4,421,418,882 is the figure which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

For and on behalf of Oilex Ltd

 

 

Joe Salomon

Managing Director

 

 

For further information, please contact:

 

Investor Enquires

Oilex Ltd

Joe Salomon

Managing Director

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel:+ 44 20 7390 0230 UK

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUVUVRAUUOARR
Date   Source Headline
7th Aug 20209:32 amRNSTermination of JPDA Arbitration Proceedings
31st Jul 202011:07 amRNSJune 2020 Quarterly Report
31st Jul 202010:45 amRNSLoan Restructure and Equity Issue
30th Jul 20209:00 amRNSManaging Director Contract Extension
27th Jul 20207:00 amRNSWest Kampar Update
17th Jul 20207:07 amRNSIssue of Securities
30th Jun 202010:40 amRNSSuccessful Bid for Cooper Basin Permit
30th Jun 20208:17 amRNSResults of General Meeting
30th Jun 20208:11 amRNSExecutive Director Contract Extension
30th Jun 20208:05 amRNSChange of Registered Office
29th Jun 20207:00 amRNSIndia Update
15th Jun 202010:28 amRNSChange to Notice of Meeting
15th Jun 20207:56 amRNSArmour Share Purchase Agreement
5th Jun 202011:52 amRNSExtension to Armour Agreement
3rd Jun 20201:14 pmRNSNotice of Change of Interest of Substantial Holder
1st Jun 20207:15 amRNSExtension to Armour Agreement
29th May 20207:00 amRNSNotice of General Meeting
27th May 20209:28 amRNSSale of Cooper Eromanga Basin Assets
26th May 20207:00 amRNSNotice of Change of Interest of Substantial Holder
15th May 20207:00 amRNSIssue of Securities
6th May 20207:00 amRNSAppendix 3Z B Lingo
6th May 20207:00 amRNSReplacement Appendix 5B
5th May 20208:36 amRNSBoard Changes
30th Apr 20209:16 amRNSMarch 2020 Quarterly Report
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
28th Apr 202011:02 amRNSCooper Basin Update
27th Apr 20207:14 amRNSCorrection: Variation to Financing Terms
23rd Apr 20201:45 pmRNSVariation to Financing Terms
3rd Apr 20207:00 amRNSChairman Consulting Contract Extension
3rd Apr 20207:00 amRNSExtension for Acquisition of Cooper Licences
26th Mar 20207:32 amRNSAppendix 3X Mark Bolton
26th Mar 20207:00 amRNSBoard and Executive Changes
24th Mar 20207:30 amRNSDoriemus Transaction - Update
16th Mar 20207:15 amRNSInterim Report 31 December 2019
16th Mar 20207:00 amRNSBusiness and Financial Restructure
12th Mar 20207:00 amRNSDoriemus Shareholders Approve Transaction
6th Mar 20207:15 amRNSOpportunity to Participate in Doriemus Offer
3rd Mar 202012:24 pmRNSUpdate on Cambay Sale Process
28th Feb 20209:29 amRNSExtension for Acquisition of Cooper Basin Licences
21st Feb 20207:30 amRNSStrong Funding Support for Cooper-Eromanga
11th Feb 20207:00 amRNSChairman Consulting Contract Extension
4th Feb 20207:00 amRNSAppendix 3B: Issue of Securities
3rd Feb 20202:23 pmRNSNew Series C Loan Facility
31st Jan 20208:17 amRNSDecember 2019 Quarterly Report
30th Jan 20207:00 amRNSDOR - Prop Acqn of Major Cooper-Eromanga Portfolio
29th Jan 202010:39 amRNSSale of Cooper Eromanga Basin Assets
28th Jan 20207:00 amRNSSale of Participating Interest in Bhandut
17th Jan 20202:05 pmRNSUpdate on Cambay Sale Process
7th Jan 20207:34 amRNSNotice of Change of Interest of Substantial Holder

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.